Evidence map›Paper›PMID 24077561›Full record

ArticleNature neuroscience2013

A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.

Tobias Goldmann, Peter Wieghofer, Philippe F Müller, Yochai Wolf, Diana Varol, Simon Yona, Stefanie M Brendecke, Katrin Kierdorf, Ori Staszewski, Moumita Datta and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 401 papers.

0numbers the graph read from it
0cells of the map it votes in
401citing papers in PubMed
30.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

401 citing papers in PubMed, 704 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Control of microglial dynamics by the Arp2/3 complex and the autism- and schizophrenia-associated protein CYFIP1.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Deletion of the X-chromosomal geneScience translational medicine · 2025
    Article
  20. Article

341 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Tobias Goldmann1] Institute of Neuropathology, University of Freiburg, Freiburg, Germany. [2].ORCID 0000000197549144
Peter Wieghofer
Philippe F Müller
Yochai Wolf
Diana Varol
Simon Yona
Stefanie M Brendecke
Katrin Kierdorf
Ori Staszewski
Moumita Datta
Tom Luedde
Mathias Heikenwalder
Steffen Jung
Marco Prinz
University of Freiburg · DEWeizmann Institute of Science · ILHelmholtz Zentrum München · DEWestfälische Hochschule · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia are brain macrophages and, as such, key immune-competent cells that can respond to environmental changes. Understanding the mechanisms of microglia-specific responses during pathologies is hence vital for reducing disease burden. The definition of microglial functions has so far been hampered by the lack of genetic in vivo approaches that allow discrimination of microglia from closely related peripheral macrophage populations in the body. Here we introduce a mouse experimental system that specifically targets microglia to examine the role of a mitogen-associated protein kinase kinase kinase (MAP3K), transforming growth factor (TGF)-β-activated kinase 1 (TAK1), during autoimmune inflammation. Conditional depletion of TAK1 in microglia only, not in neuroectodermal cells, suppressed disease, significantly reduced CNS inflammation and diminished axonal and myelin damage by cell-autonomous inhibition of the NF-κB, JNK and ERK1/2 pathways. Thus, we found TAK1 to be pivotal in CNS autoimmunity, and we present a tool for future investigations of microglial function in the CNS.

Indexed as

Gene TargetingAnimalsAnimals, NewbornAstrocytesBrainCD11c AntigenCells, CulturedCX3C Chemokine Receptor 1Disease Models, AnimalDose-Response Relationship, DrugEncephalomyelitis, Autoimmune, ExperimentalEstrogen AntagonistsGene Expression RegulationLuminescent ProteinsLymph NodesMAP Kinase Kinase Kinase 7CD11c AntigenCX3C Chemokine Receptor 1Cx3cr1 protein, mouseEstrogen AntagonistsGt(ROSA)26Sor non-coding RNA, mouseLuminescent ProteinsMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesNerve Tissue ProteinsReceptors, ChemokineRNA, UntranslatedTamoxifen

Identifiers

PMID24077561
OpenAlexW2019604999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.